Consolidated Statement of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue
Patient service revenue, net	$ 4,743,811	$ 4,018,818
Medicare shared savings revenue	767,744
Consulting revenue	432,977
Product revenue	188,588
Total revenue	6,133,120	4,018,818
Operating Expenses and Costs
Practice salaries and benefits	2,581,481	2,393,954
Other practice operating expenses	2,149,118	1,845,070
Medicare shared savings expenses	1,017,494
Cost of product revenue	146,461
Selling, general and administrative expenses	3,063,029	2,915,419
Depreciation and amortization	247,366	73,385
Total Operating Expenses and Costs	9,204,949	7,227,828
Loss from operations	(3,071,829)	(3,209,010)
Other Income (Expenses)
Loss on sales of marketable securities	(282,107)
Loss on extinguishment of debt	(1,347,371)	(1,229,777)
Change in fair value of debt	(381,835)	(121,508)
Financing cost		(135,528)
Amortization of original issue and debt discounts on notes payable and convertible notes	(530,930)	(1,260,513)
Change in fair value of derivative financial instruments	739,485	671,822
Change in fair value of contingent acquisition consideration	75,952
Loss on settlement of litigation and other dispute	(706,862)
Interest expense	(249,759)	(244,085)
Total other expenses	(2,683,427)	(2,319,589)
Net loss before provision for income taxes	(5,755,256)	(5,528,599)
Provision for income taxes
Net loss	(5,755,256)	(5,528,599)
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	(446,036)
Net loss to common stockholders	$ (6,201,292)	$ (5,528,599)
Net loss per share to common stockholders, basic and diluted:
Basic (in Dollars per share)	$ (0.04)	$ (0.06)
Fully diluted (in Dollars per share)	$ (0.04)	$ (0.06)
Weighted average number of common shares:
Basic (in Shares)	142,824,870	99,059,677
Fully diluted (in Shares)	142,824,870	99,059,677